Skip to main content
. 2013 May 31;8(5):e64979. doi: 10.1371/journal.pone.0064979

Table 1. Characteristics of 1088 HIV positive pregnant women at enrollment in the Tingathe program.

Characteristic Result
Age, mean years (SD) 27.8 (5.2)
Trimester of pregnancy: n(%)
First 54 (5.0)
Second 645 (59.3)
Third 384 (35.3)
Missing data 5 (0.4)
HIV status at enrollment, n (%)
Newly diagnosed as HIV-infected 780 (71.7)
Already known to be HIV-infected 308 (28.3)
ART eligibility at enrollment
On ART 262 (24.1)
Eligible but not on ART 307 (28.2)
Not Eligible 496 (45.6)
Missing data 23 (2.1)
CD4+ cells/mm3 at PMTCT entry for women not already on ART, n/N (%) a
≤ 250 192 (17.6)
251–349 149 (13.7)
350–499 224 (20.6)
≥500 238 (21.8)
Missing data 23 (2.1)
Partner Disclosure status at enrollment, n (%) b
Partner involved and disclosed 319 (29.3)
Partner involved, not disclosed 708 (65.1)
Partner not involved 61 (5.6)
a

Of the 1088 mother-infant pairs with first DNA PCR results, 262 mothers were already on ART, 23 with no corresponding maternal CD4 results, therefore 803 available CD4 results with corresponding PCR results.

b

Partner disclosed defined as partner having knowledge of maternal HIV status. Partner non-involved defined as a partner who has died, or is otherwise separated from the mother.

Abbreviations: ART (antiretroviral therapy), CD4+ (CD4+ cell count), PMTCT (prevention of mother-to-child transmission).